Clinical Trial Update: Randomised Double-Blind, Placebo-Controlled, Parallel Group Study in Patients With Active Rheumatoid Arthritis:Magnetic Resonance Imaging Sub-Study [Phase 2]

View source ↗

Summary

A Phase 2 randomized, double-blind, placebo-controlled study in active rheumatoid arthritis including an MRI sub-study was terminated, with results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: AstraZeneca | Conditions: Rheumatoid Arthritis | Phase 2 | Status: TERMINATED | Results posted: 2014-06-25